APEIRON Biologics



Apeiron, based in Vienna, Austria, is focused on the development of novel cancer Immunotherapies.

Peter Llewellyn-Davies
Oliver Mutschlechner
Chief Development Officer
Andreas Stadler
Director of Finance
Kerstin Westritschnig
Chief Medical Officer
Michael Ruppert
Business Development

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.